According to research underway at Brazil's Oswaldo Cruz Foundation, Brazil has a $2.4-billion deficit in API production
According to a report published in Brazil Pharma News
, and recently cited by thepharmaletter,
Brazil is failing to produce the number of APIs required to produce the drugs it needs. The nation is the sixth largest pharma market in the world, according to IMS Health, but currently makes only about 1% of its APIs. Brazil's Oswaldo Cruz Foundation has been researching this issue for some time, and recently mapped Brazilian pharma's manufacturing, technical and investmentcapacity in this area. The research aims to help create a more effective industrial policy for the pharmaceuticals sector.